(6-(1H-Pyrrol-1-yl)pyridin-3-yl)boronic acid

Catalog No. :
ACXMSV862
CAS No. :
899436-83-0
Molecular Formula :
C9H9BN2O2
Molecular Weight :
187.99

IUPAC Name:(6-(1H-pyrrol-1-yl)pyridin-3-yl)boronic acid

(6-(1H-Pyrrol-1-yl)pyridin-3-yl)boronic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$289.00Login to see priceInquiryInquiry
250mg95%$431.00Login to see priceInquiryInquiry
1g95%$1233.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(6-(1H-Pyrrol-1-yl)pyridin-3-yl)boronic acid
IUPAC Name(6-(1H-pyrrol-1-yl)pyridin-3-yl)boronic acid
MDL No.MFCD09952038
Molecular FormulaC9H9BN2O2
Molecular Weight187.99
SMILESOB(C1=CC=C(N2C=CC=C2)N=C1)O
InChI KeyFQHQYOZWZHKQCN-UHFFFAOYSA-N
Synonym6-(PYRROL-1-YL)-3-PYRIDINYL BORONIC ACID;6-(1H-Pyrrol-1-yl)pyridine-3-boronic acid;2-(1H-Pyrrol-1-yl)pyridine-5-boronic acid;Boronic acid, B-[6-(1H-pyrrol-1-yl)-3-pyridinyl]-;(6-pyrrol-1-ylpyridin-3-yl)boronic acid;6-(1-Pyrrolyl)pyridine-3-boronic Acid;B-[6-(1H-Pyrrol-1-yl)-3-pyridinyl]boronic acid
CAS No.899436-83-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACXMSV862 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXMSV862 route product structure diagram
    ACXMSV862899436-83-0
Inquiry

2. ACXMSV862 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEBUF291 route compound structure diagram
    ACEBUF2911309981-28-9 In Stock
  2. Then
  3. ACXMSV862 route product structure diagram
    ACXMSV862899436-83-0
Inquiry

Comments (0)